BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 2523688)

  • 1. New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance.
    Fernandes PB; Baker WR; Freiberg LA; Hardy DJ; McDonald EJ
    Antimicrob Agents Chemother; 1989 Jan; 33(1):78-81. PubMed ID: 2523688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
    Giovanetti E; Montanari MP; Mingoia M; Varaldo PE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1935-40. PubMed ID: 10428916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
    Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes.
    Eady EA; Ross JI; Cove JH; Holland KT; Cunliffe WJ
    J Antimicrob Chemother; 1989 Apr; 23(4):493-502. PubMed ID: 2501269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli.
    Burridge R; Warren C; Phillips I
    J Antimicrob Chemother; 1986 Mar; 17(3):315-21. PubMed ID: 3084440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.
    Sutcliffe J; Tait-Kamradt A; Wondrack L
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1817-24. PubMed ID: 8843287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
    Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
    Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
    J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain.
    Portillo A; Lantero M; GastaƱares MJ; Ruiz-Larrea F; Torres C
    Int J Antimicrob Agents; 1999 Oct; 13(2):137-40. PubMed ID: 10595574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
    Dutta GN; Devriese LA
    Res Vet Sci; 1982 Jul; 33(1):70-2. PubMed ID: 6813931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.
    Goldman RC; Kadam SK
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1058-66. PubMed ID: 2506804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem?
    Sanchez ML; Flint KK; Jones RN
    Diagn Microbiol Infect Dis; 1993; 16(3):205-13. PubMed ID: 8477574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family of r-determinants in Streptomyces spp. that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics.
    Fujisawa Y; Weisblum B
    J Bacteriol; 1981 May; 146(2):621-31. PubMed ID: 6163765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.
    Reig M; Galan J; Baquero F; Perez-Diaz JC
    Antimicrob Agents Chemother; 2001 Feb; 45(2):630-2. PubMed ID: 11158770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
    Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
    J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.
    Hardy DJ; Hensey DM; Beyer JM; Vojtko C; McDonald EJ; Fernandes PB
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1710-9. PubMed ID: 3252753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Leclercq R; Nantas L; Soussy CJ; Duval J
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():67-75. PubMed ID: 1399953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
    Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.